Press release
Opioid Withdrawal Syndrome (OWS) Market Size, Share and Trends Analysis Report By Product, By Application, By End Use, By Region And Segment Forecast 2022 to 2030 | Chiesi Farmaceutici S.p.A., Titan Pharmaceuticals, Inc., BioDelivery Sciences Internationa
Request of this Sample Report Here- https://www.astuteanalytica.com/request-sample/opioid-withdrawal-syndrome-market
The report also includes a compilation of qualitative and quantitative evaluations made by subject-matter experts in their fields and representatives from various industries found all along the supply chain.
The Global Opioid Withdrawal Syndrome (OWS) Market is estimated to witness a rise in revenue from US$ 1,068.3 Mn in 2021 to US$ 2,633.4 Mn by 2030. The market is registering a CAGR of 10.4% during the forecast period 2022-2030.
The report discusses further findings that researchers made based on the comprehensive data and offers information on the state of the market, including kinds and applications based on various nations and important locations. It describes the market's most active companies in detail, including attributes like corporate portfolio, business strategy, financial overview, recent developments, and industry share.
The leading companies in the Opioid Withdrawal Syndrome (OWS) Market include.
The key players in the Global Opioid Withdrawal Syndrome (OWS) Market are US Worldmeds LLC, Aphios Corporation, Chiesi Farmaceutici S.p.A., Titan Pharmaceuticals, Inc., BioDelivery Sciences International, Inc., Alkermes and Indivior PLC among others.
The report continuously monitors the direct impact of COVID-19, including updates on the Omicron mutation study, on the market, in addition to the indirect influence of related industries. The report contains observations on the impact of the pandemic.
Geographical regions are divided into several major categories for production, consumption, revenue (in US dollars), and market share in this analysis. The report discusses the predicted growth of the market in this region between 2021 and 2031.
More Full Report Here- https://www.astuteanalytica.com/industry-report/opioid-withdrawal-syndrome-market
The segmentation overview of the Opioid Withdrawal Syndrome (OWS) Market includes.
Lucemyra (Lofexidine)
Methadone
Buprenorphine
Naltrexone
Others (Britlofex, Masimo Bridge, etc.)
By Country segment of the Global Opioid Withdrawal Syndrome (OWS) Market is sub-segmented into:
US
EU-5
UK
Germany
France
Italy
Spain
Japan
Overall, Astute Analytica's report on the Opioid Withdrawal Syndrome (OWS) Market provides a comprehensive and valuable resource for businesses looking to understand the market's current state and future growth prospects.
Access Sample Report Here- https://www.astuteanalytica.com/request-sample/opioid-withdrawal-syndrome-market
More Report Here-
https://www.marketwatch.com/press-release/aluminum-casting-market-growth-key-factors-global-trends-industry-share-and-forecast-2023-to-2031-2023-05-23?mod=search_headline
https://www.marketwatch.com/press-release/europe-extended-reality-xr-market-trends-and-share-with-revenue-forecast-2022-to-2031-2023-05-23?mod=search_headline
About Astute Analytica:
Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.
They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.
Get in touch with us:
Phone number: +18884296757
Email: sales@astuteanalytica.com
Visit our website: https://www.astuteanalytica.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Opioid Withdrawal Syndrome (OWS) Market Size, Share and Trends Analysis Report By Product, By Application, By End Use, By Region And Segment Forecast 2022 to 2030 | Chiesi Farmaceutici S.p.A., Titan Pharmaceuticals, Inc., BioDelivery Sciences Internationa here
News-ID: 3063531 • Views: …
More Releases from Astute Analytica
Gum grafting market is set to reach valuation of US$ 892.9 million by 2033 | Ast …
Astute Analytica released an extensive market assessment report titled "Global Gum grafting market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033." This report offers a deep dive into the current landscape and future forecasts of this dynamic industry, providing valuable insights for stakeholders and industry participants.
The report thoroughly investigates the present and future scenarios of the global Gum grafting market. It highlights key trends and emerging opportunities while addressing…
Hospitals infection therapeutics market is poised to reach US$ 14.7 billion by 2 …
Astute Analytica released an extensive market assessment report titled "Global Hospital infection therapeutics market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033." This report offers a deep dive into the current landscape and future forecasts of this dynamic industry, providing valuable insights for stakeholders and industry participants.
The report thoroughly investigates the present and future scenarios of the global Hospital infection therapeutics market. It highlights key trends and emerging opportunities…
Radiopharmaceuticals market is poised to attain valuation of US$ 13.4 billion by …
Astute Analytica released an extensive market assessment report titled "Global Radiopharmaceuticals market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033." This report offers a deep dive into the current landscape and future forecasts of this dynamic industry, providing valuable insights for stakeholders and industry participants.
The report thoroughly investigates the present and future scenarios of the global Radiopharmaceuticals market. It highlights key trends and emerging opportunities while addressing challenges faced…
Hospital supplies market size is set to expand beyond US$ 125.56 billion by 2033 …
Astute Analytica released an extensive market assessment report titled "Global Hospital supplies market: Trends, Industry Competition Analysis, Revenue, and Forecast to 2033." This report offers a deep dive into the current landscape and future forecasts of this dynamic industry, providing valuable insights for stakeholders and industry participants.
The report thoroughly investigates the present and future scenarios of the global Hospital supplies market. It highlights key trends and emerging opportunities while addressing…
More Releases for Opioid
Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Opioid-Induced Constipation Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for treatment of opioid-induced constipation has seen a substantial growth recently. It is expected to escalate from a solid $1.78 billion in 2024 to an impressive $1.9 billion in 2025, exhibiting…
Growing Number Of Opioid Addiction Cases: Strategic Insights Driving Opioid Use …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Opioid Use Disorder (OUD) Market Size By 2025?
The market size for opioid use disorder (OUD) has experienced a quick expansion in the past few years. The growth is projected to rise from $3.96 billion in 2024 to $4.39 billion in 2025, boasting a compound…
Key Influencer in the Opioid-Induced Constipation Treatment Market 2025: Rising …
What combination of drivers is leading to accelerated growth in the opioid-induced constipation treatment market?
The rise in opioid administration for cancer and non-cancer pain is expected to drive the growth of the opioid-induced constipation (OIC) treatment market. Opioids are commonly used for managing moderate to severe pain, but they can cause constipation. OIC treatments are vital for improving the quality of life for patients on opioids, allowing them to maintain…
Top Factor Driving Opioid Use Disorder (OUD) Market Growth in 2025: Growing Numb …
How Are the key drivers contributing to the expansion of the opioid use disorder (oud) market?
The rise in instances of opioid dependency is set to fuel the expansion of the opioid use disorder (OUD) market. Opioid dependency defines a health concern marked by habitual and uncontrolled opioid consumption which negatively impacts health. These opioids can generate feelings of bliss and relief from pain, but continued usage often results in tolerance…
What's Driving the Opioid-Induced Constipation Treatment Market 2025-2034: Risin …
What Are the Projections for the Size and Growth Rate of the Opioid-Induced Constipation Treatment Market?
The market size for treatments of constipation caused by opioids has seen robust growth lately. The forecasted growth indicates an increase from $1.78 billion in 2024 to $1.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.0%. This past growth is associated with a growing elderly population, individualized treatments for OIC, the…
MEDICAL MARIJUANA AND THE OPIOID CRISIS
Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes. Although it has been used for decades, in the U.S., it is still illegal under federal law to use and possess marijuana.
Get PDF Sample Brochure of this report at: https://decisionmarketreports.com/request-sample/1247622
Nevertheless, at the state level, policies regarding the medical and recreational use of Cannabis vary greatly, and in many states conflict significantly with federal…
